Dr. Stefano Persiani is currently Director of Translational Sciences and Pharmacokinetics at Rottapharm Biotech, Italy. He graduated in Pharmacy at the University of Milan, Italy and completed a Post-Doctoral fellowship in the Department of Pathology of the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Dr. Persiani was later a Research Associate in the Department of Pharmaceutics of the University of Southern California, School of Pharmacy in Los Angeles, California, USA. After these academic positions he entered the pharmaceutical industry at Farmitalia Carlo Erba, Pharmacia, Upjohn, and Zambon Group and in the CRO sector as Scientific Director for Clinical Pharmacology.
Dr. Persiani in his current role applies translational approaches from drug discovery to registration in several therapeutic areas. Dr. Persiani is a member of various international scientific societies, serves on the review board of numerous professional journals, and acts as an external expert for the European Commission on the 7th Framework Program, HORIZON 2020, and Innovative Medicine Initiative.
Specialties: Drug development, biopharmaceutical development, bioequivalence, bioavailability, Phase I, IIa drug development, consultancies related to drug development courses for the University of Chieti, University of Bologna, University of Rimini. Consultancies for Thomsonreuter, IIR; Life sciences strategy, Informa life sciences, Health communication network, Vision in Business, MPG Media, European Commission 7th framework program and Innovative medicine initiative